Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/05/2220 : 31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:VBNKVersaBank
2024/05/2220 : 31PR Newswire (US)The Shyft Group Signs Agreement with Amerit Fleet Solutions 24/7 Mobile Service of Blue Arc™ EVsNASDAQ:SHYFShyft Group Inc
2024/05/2220 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGFYAgrify Corporation
2024/05/2220 : 30GlobeNewswire Inc.Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology BiosciencesBIT:1BIIBBiogen Inc
2024/05/2220 : 30GlobeNewswire Inc.Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology BiosciencesLSE:0R1BBiogen Inc
2024/05/2220 : 30GlobeNewswire Inc.EverCommerce Announces an Increase and Extension of its Share Repurchase ProgramNASDAQ:EVCMEverCommerce Inc
2024/05/2220 : 30Business WireRedwire Awarded Contract by European Space Agency to Develop Robotic Arm Prototype for Argonaut Lunar Lander to Support International Lunar ExplorationNYSE:RDWRedwire Corporation
2024/05/2220 : 30Business WireLSB Industries, Inc. Announces Landmark 5-Year Agreement to Supply Low Carbon Ammonium Nitrate SolutionNYSE:LXULSB Industries Inc
2024/05/2220 : 30GlobeNewswire Inc.Alaska Energy Metals Secures Option to Acquire the Bambino Nickel – Copper Property and Commences Exploration Programs on Its Quebec PropertiesTSXV:AEMCAlaska Energy Metals Corporation
2024/05/2220 : 30GlobeNewswire Inc.MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual MeetingNASDAQ:INKTMiNK Therapeutics Inc
2024/05/2220 : 30GlobeNewswire Inc.The Finnish Financial Supervisory Authority has approved the prospectus concerning the partial demerger of Cargotec and listing of KalmarTG:C1CCargotec Corp
2024/05/2220 : 30Business WireZai Lab Initiates Global Phase 2 Clinical Trial Evaluating ZL-1102 As a Topical Treatment for Chronic Plaque PsoriasisNASDAQ:ZLABZai Lab Ltd
2024/05/2220 : 30GlobeNewswire Inc.Ollie’s Bargain Outlet Holdings, Inc. Announces First Quarter Fiscal 2024 Release Date and Conference Call InformationNASDAQ:OLLIOllies Bargain Outlet Holdings Inc
2024/05/2220 : 30GlobeNewswire Inc.Agrify Corporation Announces Approximately $13.8 Million Debt-to-Equity ConversionNASDAQ:AGFYAgrify Corporation
2024/05/2220 : 30GlobeNewswire Inc.BrightSpring Health Services Announces Recently Closed Acquisitions in Multiple MarketsNASDAQ:BTSGBrightSpring Health Services Inc
2024/05/2220 : 30GlobeNewswire Inc.Stock Yards Bancorp Declares Quarterly Cash Dividend of $0.30 Per Common ShareNASDAQ:SYBTStock Yards Bancorp Inc
2024/05/2220 : 30GlobeNewswire Inc.Perma-Fix Announces Pricing of Approximately $20 Million Registered Direct OfferingNASDAQ:PESIPermaFix Environmental Services Inc
2024/05/2220 : 30GlobeNewswire Inc.Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology BiosciencesTG:IDPBiogen Inc
2024/05/2220 : 30GlobeNewswire Inc.Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology BiosciencesNASDAQ:BIIBBiogen Inc
2024/05/2220 : 30GlobeNewswire Inc.Enable Injections Names Matthew Huddleston as Chief Commercial Officer
2024/05/2220 : 30Business WireExact Sciences Earns 2024 Great Place To Work® Certification™NASDAQ:EXASEXACT Sciences Corporation
2024/05/2220 : 30GlobeNewswire Inc.Anavex Life Sciences Announces Expansion of Leadership TeamNASDAQ:AVXLAnavex Life Sciences Corporation
2024/05/2220 : 30GlobeNewswire Inc.Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology BiosciencesXE:IDPBiogen Inc
2024/05/2220 : 30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming June Investor ConferencesNASDAQ:RGENRepligen Corp
2024/05/2220 : 30Business WireThe TJX Companies, Inc. Reports Q1 FY25 Results; Comp Store Sales Growth of 3% at High-End of Plan; Pretax Profit Margin of 11.1% and Diluted EPS Increase of 22% Both Well Above Plan; Raises FY25 Pretax Profit Margin and EPS GuidanceNYSE:TJXTJX Companies Inc
2024/05/2220 : 30PR Newswire (US)Lielle™: Spirituality Meets Sustainability
2024/05/2220 : 30PR Newswire (US)TransDigm Announces Acquisition of SEI Industries LTD.NYSE:TDGTransdigm Group Incorporated
2024/05/2220 : 30PR Newswire (Canada)VERSABANK TO HOST SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS CONFERENCE CALL/WEBCAST WEDNESDAY, JUNE 5, 2024 at 9:00 A.M. ETTSX:VBNKVersaBank
2024/05/2220 : 30PR Newswire (US)Trinity Capital Inc. Expands Operations into EuropeNASDAQ:TRINTrinity Capital Inc
2024/05/2220 : 30PR Newswire (US)Improve Information Management in Higher Education with New Guide from Square 9